157 filings
Page 5 of 8
8-K
rbe6t7
10 Jul 18
Entry into a Material Definitive Agreement
5:18pm
8-K
pxr1ewmoabhl
3 Jul 18
Unregistered Sales of Equity Securities
4:05pm
8-K
gr0x uxr643hjvppdc
7 Jun 18
Departure of Directors or Certain Officers
4:30pm
8-K
v5en7o6a
31 May 18
Biostage Closes $3.6 Million Private Placement at a price of $3.60 per share
5:10pm
8-K
gaoqr2k4grp 43oer
25 May 18
Submission of Matters to a Vote of Security Holders
4:11pm
8-K
jc9xyv k9st
10 May 18
Biostage Reports 2018 First Quarter Financial Results
8:05am
8-K
m1mm3qe
3 May 18
Entry into a Material Definitive Agreement
5:14pm
8-K
qwq136l0
6 Apr 18
Changes in Registrant's Certifying Accountant
12:00am
8-K
27i8hh pnpjhvpdwwgdp
2 Apr 18
Biostage Reports 2017 Financial Results
12:00am
8-K
wngf3erp7neuxnh4d34
30 Mar 18
Biostage Names Distinguished Children’s Hospital Executive James Shmerling to its Board of Directors
12:00am
8-K
l9353ploe3y
22 Feb 18
Unregistered Sales of Equity Securities
12:00am
8-K
xky3ar1zlim3
14 Feb 18
Regulation FD Disclosure
12:00am
8-K
qcgnmpi
13 Feb 18
Regulation FD Disclosure
12:00am
8-K
mu6w6g0q03ast
8 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K
003gs
7 Feb 18
Biostage, Inc. Names Jason Chen Chairman of its Board of Directors
12:00am
8-K
0ksk5sq
3 Jan 18
Biostage Closes $4.2 Million Private Placement
12:00am
8-K
dhngfnz7zcru9u
22 Dec 17
Material Modifications to Rights of Security Holders
12:00am
8-K
20zeeugvr krgf5
14 Dec 17
Biostage Announces Binding Agreement For $4.0 Million Private Placement
12:00am
8-K
vs1zym7z ch0ho
7 Dec 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
7ccbcl v2cvo
12 Oct 17
Biostage Conducts Reduction In Force, Evaluating Strategic Alternatives
12:00am